Austco Healthcare (ASX:AHC) ROCE %: 20.99% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AHC Austco Healthcare Ltd ASX:AHC
56 GF Score
Price A$0.23
GF Value A$0.33
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Austco Healthcare ROCE %?

Austco Healthcare ASX:AHC 56 ROCE % is 20.99% as of Dec. 2025. GuruFocus rates ASX:AHC with a GF Score™ of 56/100 and a GF Value™ of A$0.33 (Possible Value Trap). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Austco Healthcare's annualized ROCE % for the quarter that ended in Dec. 2025 was 20.99%.

Austco Healthcare  (ASX:AHC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Austco Healthcare ROCE % Related Terms

Austco Healthcare ROCE % Historical Data

* Premium members only.

The historical data trend for Austco Healthcare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Austco Healthcare ROCE % Chart

Austco Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.68 9.84 7.54 14.83 14.74

Austco Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.94 22.98 15.54 15.02 20.99
ASX:AHC
56GF Score
Austco Healthcare Ltd ASX:AHC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Austco Healthcare ROCE % Calculation

Austco Healthcare's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=8.073/( ( (68.704 - 17.059) + (91.066 - 33.15) )/ 2 )
=8.073/( (51.645+57.916)/ 2 )
=8.073/54.7805
=14.74 %

Austco Healthcare's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=12.944/( ( (91.066 - 33.15) + (87.502 - 22.059) )/ 2 )
=12.944/( ( 57.916 + 65.443 )/ 2 )
=12.944/61.6795
=20.99 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 20.99% mean?
Austco Healthcare (ASX:AHC) has a ROCE % of 20.99% as of Dec. 2025.
Is Austco Healthcare's ROCE % too high?
Austco Healthcare's current ROCE % is 20.99%. The Medical Devices & Instruments industry median ROCE % is 2.22. Austco Healthcare's value of 20.99% is 845.5% above this industry median. Overall, Austco Healthcare has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's ROCE % compare to ISRG and BDX?
Austco Healthcare's ROCE % of 20.99% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.22. Austco Healthcare's value of 20.99% is 845.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.22, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current ROCE % of 20.99% is 845.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current ROCE % is 20.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.33, compared to a current price of A$0.23 — trading 31.8% below its estimated fair value. The current ROCE % is 20.99% and 845.5% above the Medical Devices & Instruments industry median of 2.22. Austco Healthcare's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current ROCE % is 20.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Austco Healthcare (ASX:AHC) Overvalued in 2026?

Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued. The current stock price of A$0.23 is trading 31.8% below its estimated GF Value™ of A$0.33. GuruFocus considers Austco Healthcare to be Possible Value Trap.

Key valuation signals for ASX:AHC:

  • ROCE %: 20.99%
  • GF Value™: A$0.33 vs. price of A$0.23 (31.8% below fair value)
  • GF Score™: 56/100 with 3 warning signs
  • Industry Position: 845.5% above the Medical Devices & Instruments median

No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Austco Healthcare Business Description

Address 484 Graham Street, Unit 1, Port Melbourne, Melbourne, VIC, AUS, 3207
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
56GF Score

Get the complete analysis for ASX:AHC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.23
Price
A$0.33
GF Value